RVNC•benzinga•
Revance Therapeutics Priced Upsized 8M Sharw Public Offering of Common Stock @$25/Share
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on September 13, 2022 by benzinga